Discovery may be key to obesity, diabetes Rx

Source: Discovery may be key to obesity, diabetes Rx

The relation between postprandial glucagon-like peptide-1 release and insulin sensitivity before and after bariatric surgery in humans with class II/III obesity May 5, 2021

Glucagon-like peptide-1 (GLP-1) receptor agonist treatment is beneficial for human glucose metabolism, and GLP-1 secretion is greatly enhanced following Roux-en-Y gastric bypass (RYGB).

Pim W. Gilijamse, Ahmet Demirkiran, Bart A. van Wagensveld, Mariette T. Ackermans, Johannes A. Romijn, Max Nieuwdorp, Kasper W. ter Horst, Mireille J. Serlie

Enhanced Recovery After Surgery for Sleeve Gastrectomies: Improved Patient Outcomes May 3, 2021

Enhanced Recovery After Surgery (ERAS) is a paradigm shift in perioperative care and incorporates patient-centered, evidence-based, and multidisciplinary team developed pathways for a surgical specialty. ERAS pathways aim to reduce the patient’s surgical stress response, optimize their physiologic function, facilitate recovery, and reduce length of stay. The bariatric program at our institution was previously managed […]

Ari Sapin, Patrick Hilden, Luciana Cinicolo, Jenifer Stein, Amber Turner, Prakash R. Paragi, Richard Pitera, Paul Yodice

SOARD Category 1 CME Credit Featured Articles, Volume 17, May 2021 May 1, 2021

Jin Deng, Maha Balouch, Ashley Mooney, Christopher Garnet Ducoin, Enrico M. Camporesi

Cartoon May 1, 2021

Table of Contents May 1, 2021

Discovery may be key to obesity, diabetes Rx

Related

Leave a Reply Cancel reply

Share this:

Related

Leave a Reply Cancel reply